InnoCare Pharma Ltd. (HK:9969) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
InnoCare Pharma Ltd. has received a one-month waiver from the Hong Kong Stock Exchange to appoint a new independent non-executive director, following the recent resignation of Dr. Kaixian Chen. The company is working to finalize the appointment by the end of January 2025, after facing procedural delays. This move aims to ensure compliance with stock exchange listing rules.
For further insights into HK:9969 stock, check out TipRanks’ Stock Analysis page.